Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950103-17-002312
Filing Date
2017-03-08
Accepted
2017-03-08 16:33:33
Documents
4
Effectiveness Date
2017-03-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 dp71965_s8.htm S-8 55573
2 EXHIBIT 5 dp71965_ex05.htm EX-5 28954
3 EXHIBIT 23.2 dp71965_ex2302.htm EX-23.2 2610
4 GRAPHIC image_001.jpg GRAPHIC 1080
  Complete submission text file 0000950103-17-002312.txt   89754
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216539 | Film No.: 17675519
SIC: 2834 Pharmaceutical Preparations